(Yicai) March 23 -- For more than a decade, the promise of artificial intelligence in biotechnology has centered on discovery ...
Clinical trial design decisions impact costs, access, and evidence gaps, with breast cancer as the most studied disease globally. The US leads in trial activity, with China showing rapid growth, ...
The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...
Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.
In part 3 of this three-part series, behavioral science reveals that clinical trial diversity cannot be achieved through last ...
The evolution of clinical trials shows that although much has changed, several things remain the same. When a patient expresses interest in a trial, they complete an informed consent process, and ...
LOS GATOS, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (ARDS) today announced positive feedback from the European Medicines Agency (EMA) on the Company’s proposed single ...
Preserve study integrity. Resist the temptation to bolt new exploratory endpoints midstream. If an additional endpoint is ...
BRCA1-Associated Protein 1 and Enhancer of Zeste Homolog 2: Pathway Interaction and Therapeutic Intervention in Breast Cancer, Mesothelioma, and Lymphoma Early-phase clinical trials (EPCTs) have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results